Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell Kapoor upgraded the rating for Sarepta Therapeutics, Inc. SRPT from Sell to Neutral and maintained the price target of $75. Sarepta Therapeutics shares closed at $61.91 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Jimmy Bhullar upgraded Reinsurance Group of America, Incorporated RGA from Neutral to Overweight and raised the price target from $232 to $237. Reinsurance Group shares closed at $198.27 on Tuesday. See how other analysts view this stock.
- Citigroup analyst Christopher Allen upgraded the rating for The Charles Schwab Corporation SCHW from Neutral to Buy and lifted the price target from $85 to $102. Charles Schwab shares closed at $77.67 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Will Nance upgraded Fiserv, Inc. FI from Neutral to Buy and raised the price target from $246 to $260. Fiserv shares closed at $222.01 on Tuesday. See how other analysts view this stock.
- Truist Securities analyst Bill Chappell upgraded The Scotts Miracle-Gro Company SMG from Hold to Buy and maintained the price target of $70. Scotts Miracle Gro shares closed at $54.77 on Tuesday. See how other analysts view this stock.
Considering buying SCHW stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Momentum90.92
Growth68.24
Quality–
Value15.97
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
